F+FreeMedSite USMLELearn with clinical reasoning
USMLE Step 1Intermediate → advanced clinical reasoning

Question 024 / 40 published

USMLE-STYLE CLINICAL SCENARIOSGLT2 inhibitor-associated euglycemic ketoacidosis
A 44-year-old woman with type 2 diabetes takes empagliflozin. After fasting and a minor operation, she develops abdominal pain, tachypnea and nausea. Plasma glucose is 168 mg/dL, bicarbonate 12 mmol/L, anion gap 24 mmol/L and beta-hydroxybutyrate 5.2 mmol/L. Which medication effect most directly explains the unexpectedly modest blood glucose?
Select one best answer
Next question →
← Previous